AceCounter
contents footer
  1. HOME
  2. All KODEX ETFs
  3. Product Details

Domestic Equity Sector

KODEX Healthcare(266420)

KODEX Healthcare ETF invests in KRX Healthcare Sector which represents the leading companies in Healthcare industry sector covering KOSPI and KOSDAQ market.

Last data obtained Quotes delayed at least 20 minutes. Market data provided by KOSCOM.

  • Current Price (KRW)

    11,720

    down 260 (-2.17%)

  • iNAV (KRW)

    11,749

    down 265 (-2.21%)

  • Trading Volume (shares)

    1,887

About Product

* as of Nov 20, 2019

Benchmark Index

KRX Healthcare

The KRX Autos Index is designed to track the performance of the Healthcare sector. Leading companies within the sector are chosen from a pool of both KOSPI- and KOSDAQ-listed stocks based on various standards such as market capitalization and liquidity.

View index information in detail

Key Facts

Basic Information - Net Assets, Benchmark Index, Gross Expense Ratio, Dividend, Benchmark Index, Base Currency, General Administrator, Trustee
Net Assets 8 (billion) Base Currency KRW
Inception Date March 28, 2017 General
Administrator
KSD
Gross Expense
Ratio
0.450%
(AP : 0.020%, Manager fee : 0.390%, Trustee Fee : 0.020%, General Administrator Fee : 0.020%)
Trustee KEB Hana Bank
Dividend Quarterly dividend distribution, only if applicable.
(Record date : last Business Day of January, April, July, and October)
Related
Documents
-
  • Carefully consider the Funds' investment objectives, risk factors, and charges and expenses before investing.
  • Collective investment schemes are not insured by the Korea Deposit Insurance Corporation.
  • The performance quoted represents past performance and does not guarantee future results.
  • Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold.
  • Current performance may be lower or higher than the performance quoted.
  • This information is not warranted to be accurate, complete, or timely.
  • Neither KOSCOM nor Samsung Asset Management is responsible for any damages or losses arising from any use of the information on this website.
  • This website is made in the Korean language, and if there shall arise any conflict between the Korean version and any translation thereof,
    including this -English translation, the Korean version shall prevail.

Samsung Asset Managementcompliance review No.2018-189 (2018.05.21)